Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Pharma & Biotech

Add to MyProactive

Namaste Technologies receives purchase order for product from Province of British Columbia

Full interview: Namaste Technologies receives purchase order for product from Province of British Columbia

4 weeks, 1 day ago

cannabis arrow

Buds & Duds: Cannabis stocks quiet but Namaste Technologies soars after securing new supply order from province of BC

4 weeks, 1 day ago

bevcanna bottles

Nextleaf Solutions and BevCanna Enterprises team up to bring cannabis-infused beverages to consumers

4 weeks, 1 day ago

Dyadic's president and CEO Mark A Emalfarb

Dyadic on course to disrupt the status quo in manufacturing biologic vaccines and drugs

on 09/13/2019

Kazia Therapeutics Ltd - Kazia Therapeutics wins ANZLF Trans-Tasman Innovation and Growth award

Kazia Therapeutics wins ANZLF Trans-Tasman Innovation and Growth award

on 09/12/2019

Hands holding coffee next to newspaper

NA Proactive news snapshot: Gatling Exploration, Universal mCloud, Green Organic Dutchman UPDATE...

on 09/12/2019

BevCanna Enterprises Inc -

BevCanna's chief commercialization officer to attend International Cannabis Business Conference

on 09/12/2019

cannabis stocks arrow

Buds & Duds: Cannabis stocks down across the board after Aurora Cannabis misses own guidance

on 09/12/2019

Medexus Pharmaceuticals Inc -

Medexus Pharmaceuticals receives boost for its Gliolan drug as Health Quality Ontario recommends public funding

on 09/12/2019

Namaste Technologies Inc - Namaste Technologies introduces Cultivated Beauty’s hemp-based skin care products through CannMart

Namaste Technologies introduces Cultivated Beauty’s hemp-based skincare products through CannMart

on 09/12/2019

Kazia Therapeutics Ltd - Kazia Therapeutics confirms successful completion of phase I study of its childhood cancer drug

Kazia Therapeutics confirms successful completion of phase I study of its childhood cancer drug

on 09/12/2019

Cancerous tumor

Genprex's active drug ingredient shown to prevent tumors, according to medical journal

on 09/11/2019

pills

Aequus Pharmaceuticals has the right Rx to bring new drugs to the Canadian market

on 09/10/2019

Medical person holding CBD

Buds & Duds: Cannabis stocks nudge up; Harvest One shares jump on cannabis oil license win

on 09/10/2019

Nabis Holdings Inc. - Nabis Holdings Inc of Vancouver closes on acquisition of a cultivation, production and fulfillment facility in Camp Verde, Arizona, near Phoenix

Nabis Holdings closes deal on cannabis production facility in near Phoenix

on 09/10/2019

Coffee cup and newspapers

NA Proactive news snapshot: Lydian International, CytoDyn, Pure Gold Mining, XPhyto Therapeutics UPDATE …

on 09/09/2019

Acasti Pharma receives $750,000 grant from National Research Council of Canada

Full interview: Acasti Pharma receives $750,000 grant from National Research Council of Canada

on 09/09/2019

Acasti Pharma Inc - Acasti Pharma Inc awarded $750,000 by Canadian government to help further develop its flagship prescription drug candidate CaPre designed to combat severe hypertriglyceridemia

Acasti Pharma awarded $750K by Canadian government to help develop flagship drug candidate CaPre

on 09/09/2019

CytoDyn - CytoDyn’s wins FDA approval for Phase 2 Study of leronlimab and Regorafenib as a combo therapy

CytoDyn wins FDA approval for Phase 2 Study of leronlimab and Regorafenib as combo therapy

on 09/09/2019

Kazia Therapeutics Ltd - Kazia Therapeutics' cancer drug trials push up valuation to $137 million or $2.20 a share according to Edison research

Kazia Therapeutics' cancer drug trials lift valuation to $137 million or $2.20 a share, according to Edison

on 09/09/2019